Congenital Disorders of Glycosylation
6
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Study of Hemostasis in Patients With Congenital Disorder of Glycosylation
Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism
Role of the Endothelium in Stroke-like Episode Among CDG Patients
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation